399 related articles for article (PubMed ID: 36296877)
1. SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects.
Akhtar N; Mohammed HA; Yusuf M; Al-Subaiyel A; Sulaiman GM; Khan RA
Nanomaterials (Basel); 2022 Oct; 12(20):. PubMed ID: 36296877
[TBL] [Abstract][Full Text] [Related]
2. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy.
Zhi D; Yang T; Yang J; Fu S; Zhang S
Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124
[TBL] [Abstract][Full Text] [Related]
3. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
5. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
6. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.
Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I
Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695
[TBL] [Abstract][Full Text] [Related]
7. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
Mohammed L; Ragab D; Gomaa H
Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
[TBL] [Abstract][Full Text] [Related]
8. Thermal and microwave synthesized SPIONs: Energy effects on the efficiency of nano drug carriers.
Saxena N; Agraval H; Barick KC; Ray D; Aswal VK; Singh A; Yadav UCS; Dube CL
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110792. PubMed ID: 32279785
[TBL] [Abstract][Full Text] [Related]
9. Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects.
Xu HL; Mao KL; Huang YP; Yang JJ; Xu J; Chen PP; Fan ZL; Zou S; Gao ZZ; Yin JY; Xiao J; Lu CT; Zhang BL; Zhao YZ
Nanoscale; 2016 Aug; 8(29):14222-36. PubMed ID: 27396404
[TBL] [Abstract][Full Text] [Related]
10. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
11. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications.
Lin MM; Kim DK; El Haj AJ; Dobson J
IEEE Trans Nanobioscience; 2008 Dec; 7(4):298-305. PubMed ID: 19203873
[TBL] [Abstract][Full Text] [Related]
12. Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy.
Scialabba C; Licciardi M; Mauro N; Rocco F; Ceruti M; Giammona G
Eur J Pharm Biopharm; 2014 Nov; 88(3):695-705. PubMed ID: 25281781
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles.
Zolata H; Abbasi Davani F; Afarideh H
Nucl Med Biol; 2015 Feb; 42(2):164-70. PubMed ID: 25311750
[TBL] [Abstract][Full Text] [Related]
15. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
16. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles.
Gui G; Fan Z; Ning Y; Yuan C; Zhang B; Xu Q
Int J Nanomedicine; 2021; 16():2283-2295. PubMed ID: 33776433
[TBL] [Abstract][Full Text] [Related]
17. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups.
Hong SC; Lee JH; Lee J; Kim HY; Park JY; Cho J; Lee J; Han DW
Int J Nanomedicine; 2011; 6():3219-31. PubMed ID: 22238510
[TBL] [Abstract][Full Text] [Related]
18. Luteinizing hormone-releasing hormone targeted superparamagnetic gold nanoshells for a combination therapy of hyperthermia and controlled drug delivery.
Mohammad F; Al-Lohedan HA
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():692-700. PubMed ID: 28482580
[TBL] [Abstract][Full Text] [Related]
19. External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles.
Shanehsazzadeh S; Lahooti A; Hajipour MJ; Ghavami M; Azhdarzadeh M
Colloids Surf B Biointerfaces; 2015 Dec; 136():1107-12. PubMed ID: 26613856
[TBL] [Abstract][Full Text] [Related]
20. New Frontiers in Molecular Imaging with Superparamagnetic Iron Oxide Nanoparticles (SPIONs): Efficacy, Toxicity, and Future Applications.
Frantellizzi V; Conte M; Pontico M; Pani A; Pani R; De Vincentis G
Nucl Med Mol Imaging; 2020 Apr; 54(2):65-80. PubMed ID: 32377258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
